nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0353	0.0353	CcSEcCtD
Milnacipran—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0346	0.0346	CcSEcCtD
Milnacipran—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.033	0.033	CcSEcCtD
Milnacipran—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0244	CcSEcCtD
Milnacipran—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Milnacipran—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.024	0.024	CcSEcCtD
Milnacipran—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0238	0.0238	CcSEcCtD
Milnacipran—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0228	CcSEcCtD
Milnacipran—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0225	0.0225	CcSEcCtD
Milnacipran—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0223	0.0223	CcSEcCtD
Milnacipran—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0209	CcSEcCtD
Milnacipran—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0208	CcSEcCtD
Milnacipran—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0205	CcSEcCtD
Milnacipran—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0197	CcSEcCtD
Milnacipran—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0191	CcSEcCtD
Milnacipran—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0183	CcSEcCtD
Milnacipran—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0183	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0182	CcSEcCtD
Milnacipran—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0181	0.0181	CcSEcCtD
Milnacipran—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.018	0.018	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0173	CcSEcCtD
Milnacipran—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.017	0.017	CcSEcCtD
Milnacipran—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0167	CcSEcCtD
Milnacipran—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Milnacipran—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0156	CcSEcCtD
Milnacipran—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0154	CcSEcCtD
Milnacipran—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0148	CcSEcCtD
Milnacipran—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0146	CcSEcCtD
Milnacipran—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Milnacipran—Tension—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Milnacipran—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Milnacipran—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0129	CcSEcCtD
Milnacipran—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Milnacipran—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Milnacipran—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Milnacipran—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Milnacipran—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Milnacipran—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Milnacipran—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Milnacipran—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Milnacipran—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Milnacipran—Shock—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Milnacipran—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Milnacipran—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Milnacipran—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Milnacipran—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Milnacipran—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Milnacipran—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Milnacipran—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Milnacipran—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00993	0.00993	CcSEcCtD
Milnacipran—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00991	0.00991	CcSEcCtD
Milnacipran—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00981	0.00981	CcSEcCtD
Milnacipran—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00969	0.00969	CcSEcCtD
Milnacipran—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00961	0.00961	CcSEcCtD
Milnacipran—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00953	0.00953	CcSEcCtD
Milnacipran—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00911	0.00911	CcSEcCtD
Milnacipran—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00885	0.00885	CcSEcCtD
Milnacipran—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00881	CcSEcCtD
Milnacipran—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00881	CcSEcCtD
Milnacipran—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00821	0.00821	CcSEcCtD
Milnacipran—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00799	CcSEcCtD
Milnacipran—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00788	CcSEcCtD
Milnacipran—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00762	0.00762	CcSEcCtD
Milnacipran—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00737	0.00737	CcSEcCtD
Milnacipran—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00708	CcSEcCtD
Milnacipran—Rash—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00703	CcSEcCtD
Milnacipran—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Milnacipran—Headache—Hydrochlorothiazide—nephrolithiasis	0.00698	0.00698	CcSEcCtD
Milnacipran—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00662	CcSEcCtD
